Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | DHODH | Q02127 | 2/20 | 0.36 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.35 |
| ▸ | STAT1 | P42224 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2409914 | 0.88 | PTAFR (0.35) | KMT2AMEN1TDP1KDM4ESMN1; SMN2 | |
| SCHEMBL2409916 | 0.88 | PTAFR (0.35) | KMT2AMEN1TDP1KDM4ESMN1; SMN2 | |
| SCHEMBL13515708 | 0.82 | MEN1 (0.42) | KMT2AMEN1MAPTGAATDP1 | |
| SCHEMBL14017682 | 0.81 | KMT2A (0.46) | KMT2AMEN1MAPTGAATDP1 | |
| SCHEMBL1576555 | 0.79 | LMNA (0.37) | KMT2AMEN1MAPTGAATDP1 | |
| SCHEMBL12496025 | 0.79 | LMNA (0.37) | KMT2AMEN1MAPTGAATDP1 | |
| SCHEMBL2806467 | 0.79 | LMNA (0.40) | KMT2AMEN1MAPTGAATDP1 | |
| SCHEMBL2806471 | 0.79 | LMNA (0.40) | KMT2AMEN1MAPTGAATDP1 | |
| SCHEMBL14156332 | 0.76 | MEN1 (0.60) | KMT2AMEN1MAPTGAATDP1 | |
| Malonic Acid SCHEMBL2415013 | 0.76 | LMNA (0.39) | KMT2AMEN1MAPTGAATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9364690-B2 | Composition comprising a superabsorbent polymer and a gemini surfactant | L'OREAL (FR) | 2016-06-14 | — | — | US | disclosed |
| US-20160067160-A1 | USE OF A 2-METHYLSUCCINIC ACID DIESTER DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS CONTAINING THE SAME | OREAL (FR) | 2016-03-10 | — | — | US | disclosed |
| US-20150224046-A1 | COMPOSITION CONTAINING A SUPERABSORBENT POLYMER AND AN ORGANIC UV SCREENING AGENT | L'OREAL (FR) | 2015-08-13 | — | — | US | disclosed |
| US-20130039963-A1 | COMPOSITION COMPRISING A SUPERABSORBENT POLYMER AND A GEMINI SURFACTANT | L'OREAL (FR) | 2013-02-14 | — | — | US | disclosed |
| WO-2011038778-A1 | USE OF CAPROLACTAM DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS COMPRISING IT | L'OREAL (FR) | 2011-04-07 | — | — | WO | disclosed |
| WO-2011038776-A1 | USE OF PIPERIDINE ESTER DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS COMPRISING IT | L'OREAL (FR) | 2011-04-07 | — | — | WO | disclosed |
| US-7439380-B2 | Diarylbutadiene-substituted diorganopolysiloxanes and photoprotective compositions comprised thereof | L'OREAL (FR) | 2008-10-21 | — | — | US | disclosed |
| US-20070213548-A1 | Diarylbutadiene-substituted diorganopolysiloxanes and photoprotective compositions comprised thereof | L'OREAL | 2007-09-13 | — | — | US | disclosed |
| US-7229610-B2 | Diarylbutadiene-substituted diorganopolysiloxanes and photoprotective compositions comprised thereof | L'OREAL (FR) | 2007-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070213548-A1 | Diarylbutadiene-substituted diorganopolysiloxanes and photoprotective compositions comprised thereof | XPA, ERCC4, DCLRE1A | KMT2A 3827/4885MEN1 2923/4885MAPT 3385/4885 |
| US-20150224046-A1 | COMPOSITION CONTAINING A SUPERABSORBENT POLYMER AND AN ORGANIC UV SCREENING AGENT | KRT18, FABP2, FABP4 | KMT2A 2861/4885MEN1 4735/4885MAPT 159/4885 |
| US-20160067160-A1 | USE OF A 2-METHYLSUCCINIC ACID DIESTER DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS CONTAINING THE SAME | DIMT1, FADS2, SCD | KMT2A 301/4885MEN1 1276/4885MAPT 3804/4885 |
| US-20130039963-A1 | COMPOSITION COMPRISING A SUPERABSORBENT POLYMER AND A GEMINI SURFACTANT | SGMS2, SGMS1, SCO2 | KMT2A 1965/4885MEN1 2107/4885MAPT 4476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.